Anxiolytic compounds
US8906912B2 · kind B2 · utility
5Cited by
48References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2013 |
| Grant date | Dec 9, 2014 |
| Priority date | — |
| Expiry date | Sep 18, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to chemical compounds of general formula (I)which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.